A Novel C Type CpG Oligodeoxynucleotide Exhibits Immunostimulatory Activity In Vitro and Enhances Antitumor Effect In Vivo. [PDF]
Front Pharmacol, 2020 Li T +12 more
europepmc +1 more source
CpG oligodeoxynucleotides enhance chemosensitivity of 5-fluorouracil in HepG2 human hepatoma cells via downregulation of the antiapoptotic factors survivin and livin [PDF]
, 2013 core +1 more source
Co‐administration of carcinoembryonic antigen and HIV TAT fusion protein with CpG‐oligodeoxynucleotide induces potent antitumor immunity [PDF]
, 2008 Sun‐Je Woo +8 more
openalex +1 more source
Intranasal administration of CpG oligodeoxynucleotides and antigen tolerizes against atopic responses [PDF]
, 2005 Kunihiko Kitagaki +2 more
openalex +1 more source
Maximizing CD8+ T cell responses elicited by peptide vaccines containing CpG oligodeoxynucleotides
, 2007 James N. Kochenderfer +3 more
openalex +1 more source
CpG oligodeoxynucleotides enhance Fc RI-mediated cross presentation by dendritic cells [PDF]
, 2004 Lisette Bevaart
openalex +1 more source
CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity [PDF]
, 1997 Rose S. Chu +4 more
openalex +1 more source
CpG-Oligodeoxynucleotides in Chronic Rhinosinusitis Cell Culture.
In vivo (Athens, Greece), 2016 In chronic rhinosinusitis (CRS) an important feature is the infiltration of eosinophils, triggered by T-helper type 2 cells (TH2). Binding of the CpG oligodeoxynucleotide (CpG-ODN) ligand to toll-like receptor 9 (TLR9) induces a shift from a TH2- to a TH1-type response.
Richard, Birk +6 more
openaire +1 more source